Carmed Pharmaceuticals, a Turkey-based research-driven company specializing in carvacrol-based formulations, has launched a large-scale social responsibility initiative titled "Farkındayım" as it prepares to expand into the United States. The project aims to raise awareness and generate funds for stray animals by converting digital engagement into direct contributions.
The initiative brings together 32 artists in a collaborative musical production supported by a cinematic visual narrative filmed across 17 animal shelters in nine cities throughout Turkey. A premiere event was held at Fişekhane in Istanbul on April 3, bringing together creative community members, media representatives, and project stakeholders ahead of the broader release.
"Farkındayım," which translates to "I am aware," introduces a model where every video view and music stream contributes to animal welfare efforts without requiring additional action from the audience. The project is designed to transform passive viewers into active contributors, combining art, technology, and social responsibility into a unified impact model, with proceeds directed transparently to animal welfare organizations.
"This project reflects our belief that impact should be both meaningful and measurable," said Mustafa Can, Founder of Carmed Pharmaceuticals. "We wanted to create a system where people can contribute simply by engaging, while ensuring transparency and real-world benefit."
The official video and song are available online, with the music also accessible on Spotify, including "Dikenlerin Üzerinde Yürüyorum (I Walk on Thorns)" and its instrumental version. Since its release in early April, the video has generated more than 10,000 views and over 150 audience comments, reflecting early public engagement.
While Carmed Pharmaceuticals is known for its research-driven approach to botanical formulation development, the company states that social responsibility is an integral part of its long-term vision. "Farkındayım represents how we think about impact as a company," said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. "As we expand internationally, including into the United States, we want to demonstrate that scientific development and social responsibility can move forward together."
The launch of "Farkındayım" comes as Carmed continues to expand its presence in the United States, including planned distribution through major digital platforms such as Amazon. The company's U.S. strategy focuses on building long-term credibility through research-driven product development, regulatory alignment, and increased brand visibility. As Carmed enters new markets, initiatives like "Farkındayım" are intended to reflect a broader commitment to innovation, transparency, and global impact beyond product development alone.
The official campaign video can be viewed on YouTube. Carmed Pharmaceuticals, established in 2019 following years of research and development, operates with nearly 15 years of industry experience and manufactures products in accordance with Good Manufacturing Practice (GMP) principles.
